Apple to halt sales of latest smartwatches due to patent dispute
OAN’s Brooke Mallory
1:28 PM – Monday, December 18, 2023
Due to a patent disagreement, Apple has decided to stop selling new iterations of its popular smartwatch, the company announced on Monday.
The blood-oxygen sensor on the Apple Watch Series 9 and Apple Watch Ultra 2 is the focus of the move and patent disagreement.
A federal trade regulator discovered in October that Apple had purportedly infringed upon the patent of Masimo, a medical technology business located in California. The decision prompted the Biden administration’s 60-day review period, which concludes on December 25th.
“Apple’s teams work tirelessly to create products and services that empower users with industry-leading health, wellness, and safety features,” according to the company’s statement. “Apple strongly disagrees with the order and is pursuing a range of legal and technical options to ensure that Apple Watch is available to customers.”
Masimo, on the other hand, commended the conclusion reached by the International Trade Commission.
“After a thorough multi-year legal investigation, the ITC found that Apple infringed certain of Masimo’s patented innovations for measuring blood oxygen,” Masimo said.
“The ITC’s expert judgment in this matter should be respected, protecting intellectual property rights and maintaining public trust in the United States’ patent system, and encouraging US industry,” they added.
Apple will stop selling the new smartwatch models online on December 21st.
On December 24th, retail establishments will likewise stop carrying these smartwatches. However, Apple also said that the devices will still be sold outside of the United States.
In a separate case, Massimo has been accused by Apple of copying its smartwatch’s patented features.
The Apple Watch Series 9, which debuted in September, is priced between $399 and $749, and the company highlighted the blood-oxygen sensor on the gadget as a “breathtaking innovation.”
Stay informed! Receive breaking news blasts directly to your inbox for free. Subscribe here. https://www.oann.com/alerts
Former National Security Council Special Advisor Kash Patel tells One America News that President Joe Biden’s foreign policy is making it dangerous for Americans to travel outside the country.
There are eight American hostages still in the grasp of Hamas terrorists. While President Joe Biden met with members of their families this week, the U.S. is no closer to bringing them home safely.
There seems to be a war on cattle in D.C. From the supposed climate crisis linked to the production of beef, to congress taking a second look at whole milk’s place in school cafeterias.
with Sean Whalen
Apple said it would pause sales of the smartwatches as it deals with a patent dispute over the technology that enables the blood oxygen feature on the devices.
The SEC denied a petition by the country’s largest crypto exchange Coinbase Global asking the agency to create new rules for the digital asset industry.
OpenAI CEO Sam Altman has doubled down on his vision for Worldcoin, following reports the company was seeking $50 million in funding.
Hewlett Packard said on Friday HP Inc’s finance chief Marie Myers would join the server maker as its chief financial officer.
rnrn
What is the reason behind Apple’s decision to halt the sale of Apple Watch Series 9 and Apple Watch Ultra 2 in the U.S.?
Formal Article: Apple Halts Sale of Apple Watch Series 9 and Apple Watch Ultra 2 in the U.S. Due to Patent Disagreement
An Apple watch is seen on display at the Apple Store in Grand Central Station on December 18, 2023 in New York City. Apple announced that it will halt the sale of its Apple Watch Series 9 and Apple Watch Ultra 2 in the U.S. as early as this week. (Photo by Michael M. Santiago/Getty Images)
OAN’s Brooke Mallory
1:28 PM – Monday, December 18, 2023
Due to a patent disagreement, Apple has decided to stop selling new iterations of its popular smartwatch, the company announced on Monday.
The blood-oxygen sensor on the Apple Watch Series 9 and Apple Watch Ultra 2 is the focus of the move and patent disagreement.
A federal trade regulator discovered in October that Apple had purportedly infringed upon the patent of Masimo, a medical technology business located in California. The decision prompted the Biden administration’s 60-day review period, which concludes on December 25th.
“Apple’s teams work tirelessly to create products and services that empower users with industry-leading health, wellness, and safety features,” according to the company’s statement. “Apple strongly disagrees with the order and is pursuing a range of legal and technical options to ensure that Apple Watch is available to customers.”
Masimo, on the other hand, commended the conclusion reached by the International Trade Commission.
“After a thorough multi-year legal investigation, the ITC found that Apple infringed certain of Masimo’s patented innovations for measuring blood oxygen,” Masimo said.
“The ITC’s expert judgment in this matter should be respected, protecting intellectual property rights and maintaining public trust in the United States’ patent system, and encouraging US industry,” they added.
Apple will stop selling the new smartwatch models online on December 21st.
On December 24th, retail establishments will likewise stop carrying these smartwatches. However, Apple also said that the devices will still be sold outside of the United States.
In a separate case, Massimo has been accused by Apple of copying its smartwatch’s patented features.
The Apple Watch Series 9, which debuted in September, is priced between $399 and $749, and the company highlighted the blood-oxygen sensor on the gadget as a “breathtaking innovation.”
Stay informed! Receive breaking news blasts directly to your inbox for free. Subscribe here. [hyperlink]
" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."
*As an Amazon Associate I earn from qualifying purchases
Now loading...